source Post navigation APhA 2025: Cost, Coverage, and Clinical Evidence for CGM Use in Non-Insulin Users With Type 2 Diabetes – Pharmacy Times Type 2 diabetes can worsen breast cancer outcomes – Diabetes.co.uk